Advertisement
Screener

NOVAVAX INC (NVAX) Net Margin

NOVAVAX INC (NVAX) Net Margin

  • 2026-06-30: Net Margin -94.16%.
  • 2026-03-31: Net Margin -6.80%.
  • 2025-12-31: Net Margin 11.91%.
  • 2025-09-30: Net Margin -287.29%.

Complete source-backed net margin history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical Net Margin

DateNet Margin
2026-06-30-94.16%
2026-03-31-6.80%
2025-12-3111.91%
2025-09-30-287.29%
2025-06-3044.52%
2025-03-3177.80%
2024-12-31-91.76%
2024-09-30-143.53%
2024-06-3039.08%
2024-03-31-157.21%
2023-12-31-61.23%
2023-09-30-69.94%
2023-06-3013.67%
2023-03-31-363.07%
2022-12-31-50.99%
2022-09-30-22.95%
2022-06-30-274.57%
2022-03-3128.89%
2021-12-31-380.87%
2021-09-30-180.29%
2021-06-30-118.22%
2021-03-31-49.80%
2020-12-31-63.49%
2020-09-30-125.66%
2020-06-30-49.30%
2020-03-31-765.89%
2019-12-31-361.05%
2019-09-30-719.70%
2019-06-30-1179.71%
2019-03-31-1085.33%
2018-12-31-805.19%
2018-09-30-576.21%
2018-06-30-413.00%
2018-03-31-480.18%
2017-12-31-488.30%
2017-09-30-534.09%
2017-06-30-660.50%
2017-03-31-772.08%
2016-12-31-1057.77%
2016-09-30-2050.57%
2016-06-30-3167.70%
2016-03-31-1831.48%
2015-12-31-1346.42%
2015-09-30-507.59%
2015-06-30-147.48%
2015-03-31-246.73%
2014-12-31-469.16%
2014-09-30-240.16%
2014-06-30-216.30%
2014-03-31-185.07%
2013-12-31-160.65%
2013-09-30-318.62%
2013-06-30-357.77%
2013-03-31-260.79%
2012-12-31-175.97%
2012-09-30-125.19%
2012-06-30-83.35%
2012-03-31-158.04%
2011-12-31-63.39%
2011-09-30-64.14%

Annual Net Margin

DateNet Margin
2025-12-3139.19%
2024-12-31-27.49%
2023-12-31-55.41%
2022-12-31-33.20%
2021-12-31-152.12%
2020-12-31-87.94%
2019-12-31-711.04%
2018-12-31-538.81%
2017-12-31-589.46%
2016-12-31-1823.53%
2015-12-31-432.93%
2014-12-31-270.55%
2013-12-31-248.54%
2012-12-31-129.13%
2011-12-31-131.84%
2010-12-31-10410.50%

Similar stocks

Stock NameCountryMarket CapPE Ratio
Vir Biotechnology, Inc. (VIR)United States$1.814B-6.85
Hemab Therapeutics Holdings, Inc. (COAG)United States$1.672B
Immunocore Holdings plc (IMCR)$1.613B-90.43
Taysha Gene Therapies, Inc. (TSHA)United States$1.564B-14.80
Vericel Corp (VCEL)United States$2.011B93.97
Inhibrx Biosciences, Inc. (INBX)United States$1.477B-10.08
Maze Therapeutics, Inc. (MAZE)United States$1.457B-12.40
RECURSION PHARMACEUTICALS, INC. (RXRX)United States$2.080B-3.78
Kodiak Sciences Inc. (KOD)United States$2.090B-10.12
ADMA BIOLOGICS, INC. (ADMA)United States$2.131B11.16